Dr Qing Ren, OMD, LAC, CH | |
7810 Ballantyne Commons Pkwy, Suite 300, Charlotte, NC 28277-3415 | |
(704) 968-0351 | |
Not Available |
Full Name | Dr Qing Ren |
---|---|
Gender | Female |
Speciality | Pain Medicine - Pain Medicine |
Location | 7810 Ballantyne Commons Pkwy, Charlotte, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568509297 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | TL86 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Qing Ren, OMD, LAC, CH 7810 Ballantyne Commons Pkwy, Suite 300, Charlotte, NC 28277-3415 Ph: (704) 968-0351 | Dr Qing Ren, OMD, LAC, CH 7810 Ballantyne Commons Pkwy, Suite 300, Charlotte, NC 28277-3415 Ph: (704) 968-0351 |
News Archive
The scientific spotlight focuses today on the healthful antioxidant substances in red wine, dark chocolate, olive oil, coffee, tea, and other foods and dietary supplements that are enticing millions of consumers with the promise of a healthier, longer life.
Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.
Adding the new molecularly targeted agent bortezomib to a standard chemotherapy regimen of gemcitabine and carboplatin prolongs survival in patients with advanced non-small cell lung cancer, according to results from a phase II trial.
The American Physical Society agrees with President Obama's emphasis on science in his proposed Fiscal Year 2012 budget. His priorities keep the nation on a path of scientific advancement, technological innovation and economic growth.
› Verified 3 days ago